Abstract
Fas-mediated signaling is important for lymphocyte elimination. We investigated lymphocytes for Fas-signaling defects in 20 pediatric patients with chronic hematologic autoimmunity. In 5 of 20 (25%), there was profound resistance to exogenous FasL-mediated lysis, Fas mAb, and anti-CD3. FasL function, though variable, was not significantly different from that of simultaneously evaluated controls. Only 1 patient had a Fas mutation and manifestations of autoimmune lymphoproliferative syndrome. In contrast, lymphocytes from his clinically normal mother with the same mutation were normally sensitive to FasL. In 3 patients, normal Fas-mediated lysis was restored with rhIL-2. IL-2 had no effect in the other 2 patients. Activation and proliferation functions of IL-2 were normal in all 5. We conclude that altered Fas signaling, independent of Fas mutations, can precipitate hematologic autoimmunity. IL-2 can rescue some lymphocytes from this defect. In IL-2 refractory cases, a persistently defective response to IL-2 continues to confer a lymphocyte survival advantage. Hence, altered Fas pathway signaling with or without defective IL-2 responses should be considered in the etiology of hematologic autoimmunity.
References
Jun 1, 1992·European Journal of Immunology·J H RussellR Wang
Mar 26, 1992·Nature·R Watanabe-FukunagaS Nagata
Mar 15, 1991·Proceedings of the National Academy of Sciences of the United States of America·J H RussellP Meleedy-Rey
Aug 15, 1991·Nature·H SchorleI Horak
Oct 31, 1991·Nature·M J Lenardo
Dec 21, 1990·Science·K M MurphyD Y Loh
Jun 1, 1987·Cellular Immunology·S P UmlandH R Strausser
Mar 3, 1988·Nature·J W KapplerP C Marrack
Jun 23, 1988·Nature·P KisielowH von Boehmer
Nov 3, 1988·Nature·W C ShaD Y Loh
Nov 1, 1995·European Journal of Immunology·B SadlackI Horak
Mar 25, 1994·Cell·T TakahashiS Nagata
Jan 1, 1995·The Journal of Experimental Medicine·M R AldersonD H Lynch
Jun 16, 1995·Cell·G H FisherJ M Puck
Sep 28, 1995·Nature·L ZhengM J Lenardo
Oct 1, 1995·Immunity·D M WillerfordF W Alt
Apr 15, 1993·Cellular Immunology·S Wesselborg, D Kabelitz
May 15, 1993·Proceedings of the National Academy of Sciences of the United States of America·J H RussellR Wang
May 1, 1996·International Immunology·S J TehH S Teh
Sep 1, 1996·The Journal of Clinical Investigation·J WuJ D Mountz
Sep 14, 1996·Lancet·F Le DeistA Fischer
Sep 1, 1996·European Journal of Immunology·R WangJ H Russell
Nov 28, 1996·The New England Journal of Medicine·J DrappaK B Elkon
Feb 7, 1997·Cell·S Nagata
May 1, 1997·European Journal of Immunology·A R ThileniusJ H Russell
Aug 15, 1997·The Biochemical Journal·G M Cohen
Mar 26, 1998·Cellular Immunology·R WangJ H Russell
Jun 4, 1998·Journal of Human Genetics·S Nagata
Jun 10, 1998·Immunity·Y RefaeliA K Abbas
Jun 24, 1998·Cellular Immunology·J T KungS T Ju
Oct 31, 1998·Current Opinion in Immunology·J TschoppM Thome
Apr 14, 1999·Proceedings of the National Academy of Sciences of the United States of America·D A MartinM J Lenardo
Jul 21, 1999·Cell·J WangM J Lenardo
Citations
Jun 6, 2007·Blood·Roberto StasiSergio Amadori
Sep 14, 2011·Thrombosis Research·Ning-Ning ShanMing Hou
Jul 23, 2008·La Presse médicale·Marc Michel
Nov 6, 2007·La Revue de médecine interne·M Michel
Feb 17, 2006·European Journal of Haematology·Feng ZhangMing Hou
Apr 22, 2005·Critical Reviews in Oncology/hematology·Bin ZhouZhong Chao Han
Jul 26, 2005·Seminars in Hematology·John W Semple, John Freedman
Jul 31, 2010·Blood·Lei YangMing Hou
Sep 12, 2006·Veterinary Parasitology·G K MbassaK Kauto-Mboni
Dec 12, 2003·Journal of Pediatric Hematology/oncology·John W Semple
Nov 23, 2013·Frontiers of Medicine·Xinguang LiuJun Peng
Jul 23, 2003·The Journal of Immunology : Official Journal of the American Association of Immunologists·Gudrun StraussKlaus-Michael Debatin
May 16, 2018·Frontiers in Immunology·Maurice SwinkelsA J Gerard Jansen